<DOC>
	<DOCNO>NCT00006444</DOCNO>
	<brief_summary>The purpose study see often human papillomavirus ( HPV ) occur HIV-infected woman take anti-HIV drug learn whether take anti-HIV drug affect HPV woman . HIV infection increase risk get HPV infection . Findings suggest HIV infection well weaken immune system may increase chance get HPV . Aggressive anti-HIV medication show strengthen immune system . Researchers want learn whether anti-HIV drug affect HPV virus decrease chance get HPV . This study important may provide important information help manage woman 's health determine woman 's risk develop problem cervix ( out end uterus ) .</brief_summary>
	<brief_title>The Effects Combination Anti-HIV Medication Human Papillomavirus ( HPV ) HIV-Infected Women</brief_title>
	<detailed_description>HIV infection significant risk factor human HPV infection development HPV-associated lesion female genital tract . Findings suggest HIV infection and/or HIV-related immunosuppression increase woman 's susceptibility HPV infection alters natural history preexist HPV infection . Treatment HAART show result significant increase CD4+ cell count `` partial reconstitution '' immune system . It know whether treatment HIV infection potent antiretroviral regimen could affect persistence HPV infection progression cervical dysplasia . This study important HIV-infected woman implication gynecologic management determination cervical disease risk . At baseline , Weeks 24 48 , every 48 week study completion , woman undergo pelvic examination cervical specimen collection follow method : 1 ) Sno-strip ; 2 ) cervicovaginal lavage ; 3 ) cervical brush method ; 4 ) Pap smear . A colposcopy require woman abnormal Pap smear read unless abnormal Pap smear think due intercurrent infection . A cervical biopsy strongly recommend event abnormal colposcopy . Blood collect HPV antibody test , viral load , CD4 measure .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Papilloma</mesh_term>
	<criteria>Inclusion Criteria Women may eligible study : Are HIVpositive . Are least 13 year age menstruating . Are willing enroll another drug study . Have write consent parent guardian 18 year . This study change increase enrollment . Women start HAARTbased therapy prescribe personal physician participate antiretroviral trial eligible . Intend start antiretroviral therapy within 14 day study entry . Exclusion Criteria Women eligible study : Have antiHIV treatment 14 day . Are abuse drug alcohol . Are receive medication affect immune system , fight HPV , investigational , except antiHIV drug provide coenrolling Phase II III trial approval study chair within 30 day study entry , include limited systemic interferon interleukin , thalidomide , systemic cidofovir , HPV vaccine . This study change . The following medication longer exclude : thymopentin , hydroxyurea , granulocyte colonystimulating factor ( GCSF filgrastim ) , GMCSF ( sargramostim ) . Have cervical cancer history cervical cancer . Have hysterectomy ( removal uterus ) . Participated HPV trial time . Use imiquimod inside vagina . Are take corticosteroid treatment large dos .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Drug Therapy , Combination</keyword>
	<keyword>Papillomavirus , Human</keyword>
	<keyword>DNA , Viral</keyword>
	<keyword>Anti-HIV Agent</keyword>
	<keyword>Treatment Naive</keyword>
</DOC>